SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-036179
Filing Date
2023-11-02
Accepted
2023-11-02 07:03:41
Documents
49
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fhtx-20231102.htm   iXBRL 8-K 36480
2 EX-99.1 ex991earningspressrelease1.htm EX-99.1 68603
3 EX-99.2 ex992fhtx_corpdeckxnov20.htm EX-99.2 35886
7 GRAPHIC ex992fhtx_corpdeckxnov20001.jpg GRAPHIC 77944
8 GRAPHIC ex992fhtx_corpdeckxnov20002.jpg GRAPHIC 270833
9 GRAPHIC ex992fhtx_corpdeckxnov20003.jpg GRAPHIC 104494
10 GRAPHIC ex992fhtx_corpdeckxnov20004.jpg GRAPHIC 121293
11 GRAPHIC ex992fhtx_corpdeckxnov20005.jpg GRAPHIC 95661
12 GRAPHIC ex992fhtx_corpdeckxnov20006.jpg GRAPHIC 96204
13 GRAPHIC ex992fhtx_corpdeckxnov20007.jpg GRAPHIC 51736
14 GRAPHIC ex992fhtx_corpdeckxnov20008.jpg GRAPHIC 88845
15 GRAPHIC ex992fhtx_corpdeckxnov20009.jpg GRAPHIC 136994
16 GRAPHIC ex992fhtx_corpdeckxnov20010.jpg GRAPHIC 114862
17 GRAPHIC ex992fhtx_corpdeckxnov20011.jpg GRAPHIC 131609
18 GRAPHIC ex992fhtx_corpdeckxnov20012.jpg GRAPHIC 120757
19 GRAPHIC ex992fhtx_corpdeckxnov20013.jpg GRAPHIC 119130
20 GRAPHIC ex992fhtx_corpdeckxnov20014.jpg GRAPHIC 123685
21 GRAPHIC ex992fhtx_corpdeckxnov20015.jpg GRAPHIC 60601
22 GRAPHIC ex992fhtx_corpdeckxnov20016.jpg GRAPHIC 119577
23 GRAPHIC ex992fhtx_corpdeckxnov20017.jpg GRAPHIC 87457
24 GRAPHIC ex992fhtx_corpdeckxnov20018.jpg GRAPHIC 80688
25 GRAPHIC ex992fhtx_corpdeckxnov20019.jpg GRAPHIC 66179
26 GRAPHIC ex992fhtx_corpdeckxnov20020.jpg GRAPHIC 97455
27 GRAPHIC ex992fhtx_corpdeckxnov20021.jpg GRAPHIC 89680
28 GRAPHIC ex992fhtx_corpdeckxnov20022.jpg GRAPHIC 77664
29 GRAPHIC ex992fhtx_corpdeckxnov20023.jpg GRAPHIC 59885
30 GRAPHIC ex992fhtx_corpdeckxnov20024.jpg GRAPHIC 89204
31 GRAPHIC ex992fhtx_corpdeckxnov20025.jpg GRAPHIC 95668
32 GRAPHIC ex992fhtx_corpdeckxnov20026.jpg GRAPHIC 88102
33 GRAPHIC ex992fhtx_corpdeckxnov20027.jpg GRAPHIC 64806
34 GRAPHIC ex992fhtx_corpdeckxnov20028.jpg GRAPHIC 93617
35 GRAPHIC ex992fhtx_corpdeckxnov20029.jpg GRAPHIC 89391
36 GRAPHIC ex992fhtx_corpdeckxnov20030.jpg GRAPHIC 98463
37 GRAPHIC ex992fhtx_corpdeckxnov20031.jpg GRAPHIC 50998
38 GRAPHIC ex992fhtx_corpdeckxnov20032.jpg GRAPHIC 94930
39 GRAPHIC ex992fhtx_corpdeckxnov20033.jpg GRAPHIC 123610
40 GRAPHIC ex992fhtx_corpdeckxnov20034.jpg GRAPHIC 96247
41 GRAPHIC ex992fhtx_corpdeckxnov20035.jpg GRAPHIC 104554
  Complete submission text file 0001628280-23-036179.txt   5095337

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20231102.xsd EX-101.SCH 1907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20231102_lab.xml EX-101.LAB 24846
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20231102_pre.xml EX-101.PRE 13047
43 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20231102_htm.xml XML 2829
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 231370009
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences